Irinotecan is a chemotherapy medication that is used to treat colon cancer and small cell lung cancer. It is sold under the brand name Camptosar among others. The global market for irinotecan is growing rapidly. In 2022, the market was valued at $2 billion and is projected to reach $3 billion by 2027. The growth of the market is being driven by the increasing demand for irinotecan from the pharmaceutical industry. If you are looking to buy irinotecan, there are a number of global buyers that you can contact. Here is a list of some of the top global buyers of irinotecan: SUN PHARMACEUTICAL INDUSTRIES LIMITED KAUSTUBHA SCIENTIFIC RESEARCH LABORATORY…